Fractyl Health, Inc. (GUTS) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Fractyl Health, Inc. on September 10, 2026. The filing addresses a critical corporate governance and listing status matter regarding the Company's common stock on The Nasdaq Global Market.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes and Events
- Delisting Notice: On September 10, 2026, Nasdaq notified the Company that its securities are subject to delisting due to failure to regain compliance with the Minimum Bid Price Requirement (Rule 5450(a)(1)).
- Compliance History: The Company's stock price remained below $1.00 per share for 30 consecutive business days starting March 13, 2026, and failed to recover within the 180-day grace period ending September 9, 2026.
- Reverse Stock Split Proposal: On August 24, 2026, the Company filed a proxy statement seeking stockholder approval for a reverse stock split with a ratio ranging from 1-for-5 to 1-for-15 to address the low bid price.
Outlook, Management Commentary, and Risks
- Immediate Action: The Company intends to timely request a hearing before a Nasdaq Hearings Panel. This request will automatically stay any suspension or delisting pending the conclusion of the hearing process.
- Path to Compliance: To regain compliance, the closing minimum bid price must reach at least $1.00 per share for at least 10 consecutive business days (up to 20 days at Nasdaq's discretion).
- Risks: The filing includes standard forward-looking statement disclaimers, noting that actual results may differ due to risks related to the trading price of the Common Stock and other factors disclosed in the Company's Form 10-K.
Investor Verification Checklist
- Verify the status of the stockholder vote on the proposed reverse stock split (1-for-5 to 1-for-15).
- Monitor the scheduled date and outcome of the hearing before the Nasdaq Hearings Panel.
- Track the daily closing bid price of GUTS to determine if it meets the $1.00 threshold for the required consecutive business days.
- Review the Company's most recent Form 10-K and 10-Q for detailed risk factors and financial liquidity status not included in this 8-K.